170 related articles for article (PubMed ID: 38003498)
1. Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer.
Olbromski PJ; Bogacz A; Bukowska M; Kamiński A; Moszyński R; Pawlik P; Szeliga A; Kotrych K; Czerny B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003498
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia.
Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Sadegh MH; Nematollahi MH; Rezaei M; Rasouli A; Eskandari F; Heydarabad MZ; Teimoori B; Salimi S
Apoptosis; 2019 Apr; 24(3-4):301-311. PubMed ID: 30701356
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia.
Fernandes AT; Rocha NP; Vendrame E; Russomano F; Grinsztejn BJ; Friedman RK; Pinto AC; Klumb EM; Avvad E; Macedo J; Martínez-Maza O; Bonecini-Almeida Mda G
Apoptosis; 2015 Oct; 20(10):1347-57. PubMed ID: 26272263
[TBL] [Abstract][Full Text] [Related]
4. BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.
Moschos MM; Chatziralli I; Brouzas D; Gazouli M
Ophthalmic Res; 2017; 58(4):227-230. PubMed ID: 28877516
[TBL] [Abstract][Full Text] [Related]
5. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
[TBL] [Abstract][Full Text] [Related]
7. BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.
Chatterjee K; De S; Deb Roy S; Sahu SK; Chakraborty A; Ghatak S; Das N; Mal S; Roy Chattopadhyay N; Das P; Reddy RR; Mukherjee S; Das AK; Puii Z; Zomawia E; Singh YI; Tsering S; Riba K; Rajasubramaniam S; Suryawanshi AR; Choudhuri T
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1171-1181. PubMed ID: 33906310
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
9. Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
Oliveira C; Lourenço GJ; Rinck-Junior JA; Cintra ML; Moraes AM; Lima CS
J Dermatol Sci; 2014 May; 74(2):135-41. PubMed ID: 24461648
[TBL] [Abstract][Full Text] [Related]
10. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the mRNA expression levels of BCL2 and BAX genes in human osteoarthritis and normal articular cartilage: An investigation into their differential expression.
Karaliotas GI; Mavridis K; Scorilas A; Babis GC
Mol Med Rep; 2015 Sep; 12(3):4514-4521. PubMed ID: 26081683
[TBL] [Abstract][Full Text] [Related]
12. Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (
Moawadh MS; Mir R; Tayeb FJ; Asim O; Ullah MF
Curr Issues Mol Biol; 2023 May; 45(5):3933-3952. PubMed ID: 37232720
[TBL] [Abstract][Full Text] [Related]
13. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.
Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon YD; Harsum S; MacLaren RE; Charteris DG; Van Meurs JC; González-Sarmiento R; Pastor JC;
Acta Ophthalmol; 2015 Nov; 93(7):e541-9. PubMed ID: 25991504
[TBL] [Abstract][Full Text] [Related]
14. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
Jiang X; Tsang YH; Yu Q
Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
[TBL] [Abstract][Full Text] [Related]
15. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
[TBL] [Abstract][Full Text] [Related]
16. A Study Investigating the Role of 2 Candidate SNPs in Bax and Bcl-2 Genes in Alzheimer's Disease.
Erdal ME; Görücü Yilmaz S; Ay ME; Güler Kara H; Avci Özge A; Tasdelen B
P R Health Sci J; 2020 Sep; 39(3):264-269. PubMed ID: 33031695
[TBL] [Abstract][Full Text] [Related]
17. Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure.
Ortiz A; Lorz C; Catalán MP; Danoff TM; Yamasaki Y; Egido J; Neilson EG
Kidney Int; 2000 Mar; 57(3):969-81. PubMed ID: 10720950
[TBL] [Abstract][Full Text] [Related]
18. Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer.
Heubner M; Wimberger P; Otterbach F; Kasimir-Bauer S; Siffert W; Kimmig R; Nückel H
Int J Biol Markers; 2009; 24(4):223-9. PubMed ID: 20082279
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of
Al-Zubaidy HFS; Majeed SR; Al-Koofee DAF
Arch Razi Inst; 2022 Apr; 77(2):799-808. PubMed ID: 36284943
[TBL] [Abstract][Full Text] [Related]
20. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
